1. SAT0639 Biologic-eligible rheumatoid arthritis patients demonstrate absence of synovitis – utility of ultrasound in the management of ra-biologic population. (15th June 2017) Authors: Naraghi, K; Vojinovic, T; Nam, J; Freeston, J; Emery, P; Wakefield, RJ; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0390 European multicentre study validates elf test as biomarker of fibrosis in systemic sclerosis. (15th June 2017) Authors: Abignano, G; Blagojevic, J; Bissell, L-A; Dumitru, RB; Eng, S; Allanore, Y; Avouac, J; Bosello, S; Denton, C; Distler, O; Ferraccioli, G; Jordan, S; Matucci-Cerinic, M; Ong, V; Messenger, M; Hutchinson, M; Buch, MH; Emery, P; Galdo, F Del Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P026 Control of Α2, 6-sialylation in B-cells, and consequences of reduced B-cell sialylation in patients with rheumatoid arthritis. (March 2019) Authors: Johnston, L; Ouboussad, L; Aslam, A; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A2.36 Dynamics of T-cell subset in early ra patients treated with mtx or MTX+ANTI-TNF. (24th February 2016) Authors: Wigston, Z; Buch, MH; Burska, A; Emery, P; Ponchel, F Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A2.40 Investigating IL-6 pathway signalling kinetics in peripheral blood single cell subsets with tocilizumab therapy in patients with early rheumatoid arthritis. (24th February 2016) Authors: Ouboussad, L; Wong, C; Hunt, L; Emery, P; McDermott, MF; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0101 Cardiovascular magnetic resonance imaging characterisation of cardiovascular abnormalities in individuals at risk of developing rheumatoid arthritis. (15th June 2017) Authors: Fent, GJ; Hunt, L; Mankia, KS; Erhayiem, B; Foley, JR; Garg, P; Swoboda, PP; Andrews, J; Greenwood, JP; Emery, P; Plein, S; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A2.42 Clinical utility of measuring naÏve CD4+T-cell in early ra patient to predict remission on mtx: A replication study. (24th February 2016) Authors: Ponchel, F; Hunt, L; Burska, AN; Parmar, R; Buch, MH; Emery, P Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A7.2 Identification of predictive micro-RNAs of progression from PRE-RA systemic autoimmunity to development of RA using matched serum samples. (13th February 2015) Authors: Ouboussad, L; Hunt, L; Hensor, EMA; Wong, C; Emery, P; McDermott, MF; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P152 Interferon-I activity in early and estblished rheumatoid arthritis (RA) with and without cardiovascular abnormalities in cardiac magnetic resonance (CMR). (March 2019) Authors: Burska, AN; Harrison, G; El-Sherbiny, Y; Bissell, L-A; Giollo, A; Hensor, EM; Fent, G; Erhayiem, B; Greenwood, J; Plein, S; Andrews, J; Vital, E; Buch, MH Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0556 Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. (15th June 2017) Authors: Yusof, MY Md; Vital, EM; McElvenny, D; Hensor, EM; Das, S; Buch, MH; Emery, P; Savic, S Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗